Emile-Victor Kuyl1, Fei Shu1, Branden R Sosa1,2, Juan D Lopez1,2, Di Qin1,3, Tania Pannellini4, Lionel B Ivashkiv5, Matthew B Greenblatt6,7, Mathias P G Bostrom1,2,8, Xu Yang1. 1. Arthroplasty Research Laboratory, Research Institute, Hospital for Special Surgery, New York, New York, USA. 2. Weill Cornell Medicine, New York, New York, USA. 3. Department of Orthopaedic Surgery, Third Hospital of Hebei Medical University, Shijiazhuang, China. 4. Research Institute and Precision Medicine Laboratory, Hospital for Special Surgery, New York, New York, USA. 5. Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, New York, USA. 6. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA. 7. Research Institute, Hospital for Special Surgery, New York, New York, USA. 8. Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York, USA.
Abstract
AIMS: Aseptic loosening is a leading cause of uncemented arthroplasty failure, often accompanied by fibrotic tissue at the bone-implant interface. A biological target, neutrophil extracellular traps (NETs), was investigated as a crucial connection between the innate immune system's response to injury, fibrotic tissue development, and proper bone healing. Prevalence of NETs in peri-implant fibrotic tissue from aseptic loosening patients was assessed. A murine model of osseointegration failure was used to test the hypothesis that inhibition (through Pad4-/- mice that display defects in peptidyl arginine deiminase 4 (PAD4), an essential protein required for NETs) or resolution (via DNase 1 treatment, an enzyme that degrades the cytotoxic DNA matrix) of NETs can prevent osseointegration failure and formation of peri-implant fibrotic tissue. METHODS: Patient peri-implant fibrotic tissue was analyzed for NETs biomarkers. To enhance osseointegration in loose implant conditions, an innate immune system pathway (NETs) was either inhibited (Pad4-/- mice) or resolved with a pharmacological agent (DNase 1) in a murine model of osseointegration failure. RESULTS: NETs biomarkers were identified in peri-implant fibrotic tissue collected from aseptic loosening patients and at the bone-implant interface in a murine model of osseointegration failure. Inhibition (Pad4-/- ) or resolution (DNase 1) of NETs improved osseointegration and reduced fibrotic tissue despite loose implant conditions in mice. CONCLUSION: This study identifies a biological target (NETs) for potential noninvasive treatments of aseptic loosening by discovering a novel connection between the innate immune system and post-injury bone remodelling caused by implant loosening. By inhibiting or resolving NETs in an osseointegration failure murine model, fibrotic tissue encapsulation around an implant is reduced and osseointegration is enhanced, despite loose implant conditions. Cite this article: Bone Joint J 2021;103-B(7 Supple B):135-144.
AIMS: Aseptic loosening is a leading cause of uncemented arthroplasty failure, often accompanied by fibrotic tissue at the bone-implant interface. A biological target, neutrophil extracellular traps (NETs), was investigated as a crucial connection between the innate immune system's response to injury, fibrotic tissue development, and proper bone healing. Prevalence of NETs in peri-implant fibrotic tissue from aseptic loosening patients was assessed. A murine model of osseointegration failure was used to test the hypothesis that inhibition (through Pad4-/- mice that display defects in peptidyl arginine deiminase 4 (PAD4), an essential protein required for NETs) or resolution (via DNase 1 treatment, an enzyme that degrades the cytotoxic DNA matrix) of NETs can prevent osseointegration failure and formation of peri-implant fibrotic tissue. METHODS: Patient peri-implant fibrotic tissue was analyzed for NETs biomarkers. To enhance osseointegration in loose implant conditions, an innate immune system pathway (NETs) was either inhibited (Pad4-/- mice) or resolved with a pharmacological agent (DNase 1) in a murine model of osseointegration failure. RESULTS: NETs biomarkers were identified in peri-implant fibrotic tissue collected from aseptic loosening patients and at the bone-implant interface in a murine model of osseointegration failure. Inhibition (Pad4-/- ) or resolution (DNase 1) of NETs improved osseointegration and reduced fibrotic tissue despite loose implant conditions in mice. CONCLUSION: This study identifies a biological target (NETs) for potential noninvasive treatments of aseptic loosening by discovering a novel connection between the innate immune system and post-injury bone remodelling caused by implant loosening. By inhibiting or resolving NETs in an osseointegration failure murine model, fibrotic tissue encapsulation around an implant is reduced and osseointegration is enhanced, despite loose implant conditions. Cite this article: Bone Joint J 2021;103-B(7 Supple B):135-144.
Authors: Christoph Daniel; Moritz Leppkes; Luis E Muñoz; Gunnar Schley; Georg Schett; Martin Herrmann Journal: Nat Rev Nephrol Date: 2019-06-18 Impact factor: 28.314
Authors: Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad Journal: Science Date: 2018-09-28 Impact factor: 47.728
Authors: Mathilde Gavillet; Kimberly Martinod; Raffaele Renella; Chad Harris; Nate I Shapiro; Denisa D Wagner; David A Williams Journal: Am J Hematol Date: 2015-10-06 Impact factor: 10.047
Authors: Zhi-Wei Lai; Robert Hanczko; Eduardo Bonilla; Tiffany N Caza; Brandon Clair; Adam Bartos; Gabriella Miklossy; John Jimah; Edward Doherty; Hajra Tily; Lisa Francis; Ricardo Garcia; Maha Dawood; Jianghong Yu; Irene Ramos; Ioana Coman; Stephen V Faraone; Paul E Phillips; Andras Perl Journal: Arthritis Rheum Date: 2012-09
Authors: Peter Bankhead; Maurice B Loughrey; José A Fernández; Yvonne Dombrowski; Darragh G McArt; Philip D Dunne; Stephen McQuaid; Ronan T Gray; Liam J Murray; Helen G Coleman; Jacqueline A James; Manuel Salto-Tellez; Peter W Hamilton Journal: Sci Rep Date: 2017-12-04 Impact factor: 4.379
Authors: Hillary G Pratt; Kayla J Steinberger; Nicole E Mihalik; Sascha Ott; Thomas Whalley; Barbara Szomolay; Brian A Boone; Timothy D Eubank Journal: Cancers (Basel) Date: 2021-12-31 Impact factor: 6.639
Authors: Kevin Staats; Branden R Sosa; Emile-Victor Kuyl; Yingzhen Niu; Vincentius Suhardi; Kathleen Turajane; Reinhard Windhager; Matthew B Greenblatt; Lionel Ivashkiv; Mathias P G Bostrom; Xu Yang Journal: Bone Joint Res Date: 2022-05 Impact factor: 4.410